Skip to content Skip to footer

Leafly Announced as Headline Sponsor of Business of Cannabis: New York

Leafly Announced as Headline Sponsor of Business of Cannabis: New York
Share this story
  • Leafly is the headline sponsor of the Business of Cannabis: New York summit on September 29.
  • Headset, the Canadian Securities Exchange (CSE) and Conor Green Consulting are also sponsoring the summit.
  • Leafly CEO, Yoko Miyashita, Headset CEO, Cy Scott, and Richard Carleton, CEO of the Canadian Securities Exchange, will also speak at the exclusive industry leaders summit at Rainbow Room, Rockefeller Center, New York City.
  • Prohibition Partners forecasts that the legal cannabis market in New York will be worth USD$2.6 billion in 2022, rising to USD$3.9 billion by 2025.
  • In March 2021, Governor Andrew Cuomo signed into law the groundbreaking bill to legalise cannabis and, with it, created the industry’s new global capital.

Leafly, the world’s most trusted destination to discover and order cannabis products, has been confirmed as the headline sponsor for the Business of Cannabis: New York summit on September 29.

The partnership comes after a busy period for Leafly’s executive team, during which time the Washington-based cannabis technology firm announced its intentions to go public through a SPAC merger with Merida Merger Corp., in a deal worth a reported $532 million.

Leafly CEO, Yoko Miyashita, has also been confirmed as a speaker at the Business of Cannabis: New York summit. Speaking about the event on September 29, Yoko said: “This is a pivotal moment for the cannabis industry — and New York is at the center of it. Legalization in New York will set the tone for East Coast markets, push forward the fight for federal legalization, and define new and essential on-ramps to economic opportunity for those unfairly targeted by the War on Drugs. Leafly is excited to partner with the Business of Cannabis and Prohibition Partners to celebrate those who will define the future for one of the fastest growing industries in New York and our country: cannabis.” 

Headset Inc., a business intelligence platform for the cannabis industry, the Canadian Securities Exchange, and Conor Green Consulting, a specialist have also signed agreements to sponsor the summit in New York. Headset CEO, Cy Scott, and Richard Carleton, CEO of the Canadian Securities Exchange, will join Yoko Miyashita on the roster of speakers for the summit.

On the announcement of headline sponsors and speakers, Jay Rosenthal, President of Business of Cannabis, said: “No company in the cannabis sector has as broad, as deep and as important a reach as Leafly. Hearing from their CEO as part of our event in the heart of the emerging hub of New York will be a major cannabis sector moment.

The New Capital of Cannabis?

Business of Cannabis: New York will take place at the Rainbow Room, Rockefeller Center, on September 29. The new and exclusive cannabis conference will bring together over 300 of the most influential leaders in policy, business, law and finance to develop a workable roadmap for the legal cannabis industry in New York.

A day-long program of knowledge-sharing and networking will form the foundations of an exciting future for New York’s legal cannabis industry.

By convening Business of Cannabis: New York, those that have shaped – and will shape – the future of the sector will be able to network, learn and build the sector together – in person, and for the first time since New York legalized cannabis.

Prohibition Partners forecasts that the legal cannabis market in New York will be worth USD$2.6 billion in 2022, rising to USD$3.9 billion by 2025.

The day-long Business of Cannabis: New York summit is presented in partnership by Business of Cannabis and Prohibition Partners.

Prohibition Partners unlocks the potential of cannabis through data, analysis and intelligence. It provides advisory services and strategic solutions to an international client base of investors, operators, blue chips and government organisations.

Business of Cannabis is one of the leading B2B media platforms for the North American cannabis industry.

For media enquiries, please contact Michael Hoban, Head of Marketing & Comms – michael@prohibitionpartners.com

For sponsorship opportunities, please contact Matt Freemantle, Events Director – matt@prohibitionpartners.com

Recent posts
June 2, 2022
Austria Sees Record Imports of Medical Cannabis in 2021
May 19, 2022
Who Are Europe’s Medical Cannabis Patients?
May 5, 2022
Europe’s Pilot Trials Are a Tentative Step Towards Legal Medical Cannabis
April 28, 2022
The First Sales of Legal Adult-Use Cannabis in Europe Are Due in 2022

Catch up on our newest articles that you might have missed

joss-woodhead-3wFRlwS91yk-unsplash
June 2, 2022
Austria Sees Record Imports of Medical Cannabis in 2021
Austria sees record imports of medical cannabis in 2021 while a case at the Supreme Court challenges prohibition. Austria is...
Untitled design (11)
May 19, 2022
Who Are Europe’s Medical Cannabis Patients?
The relatively close integration of medical cannabis into the European healthcare systems has contributed to a patient population and purchasing...
il-vagabiondo-Q7QCj-9-q3I-unsplash
May 5, 2022
Europe’s Pilot Trials Are a Tentative Step Towards Legal Medical Cannabis
Underlining the cautious approach Europe is taking to the liberalisation of medical cannabis are the pilot trial access schemes for...
vincent-ghilione-z54zUmYA9f8-unsplash
April 28, 2022
The First Sales of Legal Adult-Use Cannabis in Europe Are Due in 2022
Last week the first pilot project trial for the legalised sales of adult-use cannabis in Basel, Switzerland was approved by...